Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
November 05, 2026 5.317
November 04, 2026 4.374
November 03, 2026 3.755
November 02, 2026 3.744
October 30, 2026 3.804
October 29, 2026 4.008
October 28, 2026 4.024
October 27, 2026 3.658
October 26, 2026 3.453
October 23, 2026 3.577
October 22, 2026 3.653
October 21, 2026 3.615
October 20, 2026 3.534
October 19, 2026 3.335
October 16, 2026 3.108
October 15, 2026 3.324
October 14, 2026 3.249
October 13, 2026 3.286
October 12, 2026 3.518
October 09, 2026 3.620
October 08, 2026 3.464
October 07, 2026 3.367
October 06, 2026 3.340
October 05, 2026 3.399
October 02, 2026 3.399
Date Value
October 01, 2026 3.410
September 30, 2026 3.372
September 29, 2026 3.607
September 28, 2026 3.642
September 25, 2026 3.630
September 24, 2026 3.694
September 23, 2026 3.712
September 22, 2026 4.196
September 21, 2026 3.794
September 18, 2026 3.893
September 17, 2026 3.893
September 16, 2026 3.869
September 15, 2026 3.858
September 14, 2026 4.004
September 11, 2026 4.184
September 10, 2026 4.225
September 09, 2026 4.231
September 08, 2026 4.319
September 04, 2026 4.360
September 03, 2026 4.301
September 02, 2026 4.348
September 01, 2026 4.459
August 31, 2026 4.459
August 28, 2026 4.540
August 27, 2026 4.902

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.35
Anika Therapeutics, Inc. 1.884
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.003

Price to Book Value Related Metrics

PS Ratio 5.319
Price 9.87
Earnings Yield -13.01%
Market Cap 275.30M